Document Detail


Cefazolin is inferior to cefotetan as single-dose prophylaxis for women undergoing elective total abdominal hysterectomy.
MedLine Citation:
PMID:  7756495     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The purpose of this prospective, randomized, double-blind clinical trial was to compare the efficacy of 1-g doses of intravenous cefazolin with that of 1-g doses of intravenous cefotetan in preventing major operative site infections after elective abdominal hysterectomy. A major operative site infection requiring parenteral antimicrobial therapy developed in 46 (9%) of 511 evaluable women: 30 (11.6%) of 258 women given cefazolin prophylaxis and 16 (6.3%) of 253 women given cefotetan prophylaxis (relative risk, 1.84; 95% confidence interval, 1.03 to 3.29; P < .05). Risk factors for major operative site infection were younger age, lower postoperative hemoglobin concentration, and a proliferative endometrium. Ten (3.9%) of 258 women given cefazolin prophylaxis had a postoperative pelvic abscess; two of these women required additional surgical procedures, compared with two (0.8%) of 253 women given cefotetan prophylaxis who had an abscess but did not require surgery (relative risk, 4.9; 95% confidence interval, 1.09 to 22.16; P = .04). A greater number of infections and more serious infections occurred following cefazolin prophylaxis; this treatment resulted in 234 additional hospital days for administration of parenteral antimicrobial therapy.
Authors:
D L Hemsell; E R Johnson; P G Hemsell; B J Nobles; B B Little; M C Heard
Related Documents :
10522655 - Influence of education on risk of hysterectomy before age 45 years.
20880745 - Endometrial implantation factors in women with submucous uterine fibroids.
21366755 - The use of contraception by women with intellectual disabilities.
8540295 - Hysterectomy increases the symptomatology of postmenopausal syndrome.
25193535 - Postpartum glucose tolerance in women with gestational diabetes using levonorgestrel in...
2344565 - Coronary artery disease in women.
Publication Detail:
Type:  Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America     Volume:  20     ISSN:  1058-4838     ISO Abbreviation:  Clin. Infect. Dis.     Publication Date:  1995 Mar 
Date Detail:
Created Date:  1995-06-29     Completed Date:  1995-06-29     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  9203213     Medline TA:  Clin Infect Dis     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  677-84     Citation Subset:  IM    
Affiliation:
Department of Obstetrics and Gynecology, University of Texas Southwestern Medical Center at Dallas 75235-9032, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Cefazolin / administration & dosage,  therapeutic use*
Cefotetan / administration & dosage,  therapeutic use*
Double-Blind Method
Female
Follow-Up Studies
Humans
Hysterectomy*
Microbial Sensitivity Tests
Middle Aged
Prospective Studies
Risk Factors
Surgical Procedures, Elective
Surgical Wound Infection / microbiology,  prevention & control*
Chemical
Reg. No./Substance:
25953-19-9/Cefazolin; 69712-56-7/Cefotetan

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Diminished activity of ceftizoxime in comparison to cefotaxime and ceftriaxone against Streptococcus...
Next Document:  Steroid therapy for bacterial meningitis.